{"text": ["Novartis", "buys", "Takeda's", "dry", "eye", "drug", "for", "$3.4", "bln"], "created_at": "2019-05-08 23:38:17"}
{"text": ["Novartis", "buys", "dry-eye", "drug", "Xiidra", "rights", "from", "Takeda", "for", "$3.4", "billion"], "created_at": "2019-05-08 22:48:00"}
{"text": ["Novartis", "buys", "Takeda's", "dry", "eye", "drug", "for", "$3.4", "bln"], "created_at": "2019-05-08 22:38:53"}
{"text": ["Aduro", "(ADRO)", "Q1", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-05-08 17:54:35"}
{"text": ["Aduro", "(ADRO)", "Q1", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-05-08 17:54:35"}
{"text": ["Novartis", "confident", "of", "Zolgensma", "supply,", "calls", "$2", "million", "price", "\"speculation\""], "created_at": "2019-05-08 17:49:46"}
{"text": ["Aduro", "(ADRO)", "Q1", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-05-08 16:06:04"}
{"text": ["Validea", "Peter", "Lynch", "Strategy", "Daily", "Upgrade", "Report", "-", "5/8/2019"], "created_at": "2019-05-08 08:09:08"}
{"text": ["Validea", "Peter", "Lynch", "Strategy", "Daily", "Upgrade", "Report", "-", "5/8/2019"], "created_at": "2019-05-08 08:09:08"}
